{"meshTagsMajor":["Exons"],"keywords":["Acquired resistance","Adenocarcinoma","EGFR mutation","EML4-ALK fusion","Lung"],"meshTags":["Adenocarcinoma","Exons","Gene Deletion","Humans","Lung Neoplasms","Male","Middle Aged","Oncogene Proteins, Fusion","Receptor, Epidermal Growth Factor"],"meshMinor":["Adenocarcinoma","Gene Deletion","Humans","Lung Neoplasms","Male","Middle Aged","Oncogene Proteins, Fusion","Receptor, Epidermal Growth Factor"],"genes":["EGFR","EML4","ALK","epidermal growth factor receptor","EGFR","echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase","EML4-ALK"],"organisms":["9606","9606"],"publicationTypes":["Case Reports","Journal Article"],"abstract":"We report a man with advanced adenocarcinoma who harboring exon 19 (E746-A750del) epidermal growth factor receptor (EGFR) deletion and echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase (EML4-ALK) gene translocation in the re-biospy specimen. The patient was treated with erlotinib with a stable disease but progressed slowly, while crizotinib showed a complete response. ","title":"A case of lung adenocarcinoma harboring exon 19 EGFR deletion and EML4-ALK fusion gene.","pubmedId":"23731739"}